TY - JOUR AU - Antunes, M. A. AU - Laffey, J. G. AU - Pelosi, P. AU - Rocco, P. R. M. PY - 2014 DA - 2014// TI - Mesenchymal stem cell trials for pulmonary diseases JO - J Cell Biochem VL - 115 UR - https://doi.org/10.1002/jcb.24783 DO - 10.1002/jcb.24783 ID - Antunes2014 ER - TY - JOUR AU - Williams, A. R. AU - Hare, J. M. PY - 2011 DA - 2011// TI - Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease JO - Circ Res VL - 109 UR - https://doi.org/10.1161/CIRCRESAHA.111.243147 DO - 10.1161/CIRCRESAHA.111.243147 ID - Williams2011 ER - TY - JOUR AU - Drela, K. AU - Siedlecka, A. AU - Sarnowska, A. AU - Domanskajanik, K. PY - 2013 DA - 2013// TI - Human mesenchymal stem cells in the treatment of neurological diseases JO - Acta Neurobiol Exp (Wars) VL - 73 ID - Drela2013 ER - TY - JOUR AU - Bovenberg, M. S. S. AU - Degeling, M. H. AU - Tannous, B. A. PY - 2013 DA - 2013// TI - Advances in stem cell therapy against gliomas JO - Trends Mol Med VL - 19 UR - https://doi.org/10.1016/j.molmed.2013.03.001 DO - 10.1016/j.molmed.2013.03.001 ID - Bovenberg2013 ER - TY - JOUR AU - Kebriaei, P. AU - Saliba, R. AU - Rondon, G. AU - Chiattone, A. AU - Luthra, R. AU - Anderlini, P. PY - 2012 DA - 2012// TI - Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes JO - Biol Blood Marrow Transplant VL - 18 UR - https://doi.org/10.1016/j.bbmt.2011.08.011 DO - 10.1016/j.bbmt.2011.08.011 ID - Kebriaei2012 ER - TY - JOUR AU - Yuan, B. Z. AU - Wang, J. PY - 2014 DA - 2014// TI - The regulatory sciences for stem cell-based medicinal products JO - Front Med VL - 8 UR - https://doi.org/10.1007/s11684-014-0323-5 DO - 10.1007/s11684-014-0323-5 ID - Yuan2014 ER - TY - JOUR AU - Li, Y. V. F. AU - Wang, B. AU - Gu, N. PY - 2019 DA - 2019// TI - Regulations on cell therapy products in China: a brief history and current status JO - Regen Med VL - 14 UR - https://doi.org/10.2217/rme-2019-0069 DO - 10.2217/rme-2019-0069 ID - Li2019 ER - TY - BOOK PY - 2015 DA - 2015// TI - Notice on guidelines for quality control and preclinical research (trials) on stem cell preparations ID - ref8 ER - TY - BOOK PY - 2015 DA - 2015// TI - Notice on stem cell clinical trial research management approach (trial) ID - ref9 ER - TY - BOOK PY - 2015 DA - 2015// TI - Notice about application as a stem cell clinical research institution ID - ref10 ER - TY - STD TI - National Health and Family Planning Commission of China & China Food and Drug Administration. Technical guideline for research and evaluation of cell products. Draft for comment; 2016. https://www.cde.org.cn/news.do?method=viewInfoCommon&id=313749. UR - https://www.cde.org.cn/news.do?method=viewInfoCommon&id=313749 ID - ref11 ER - TY - BOOK PY - 2017 DA - 2017// TI - Notice on strengthening the preparation and supervision of stem cell clinical research ID - ref12 ER - TY - STD TI - ISSCR. Guidelines for stem cell research and clinical translation. ISSCR; 2016/05/12. https://www.isscr.org/news-publicationsss/isscr-news-articles/article-detail/2016/05/12/isscr-releases-updated-guidelines-for-stem-cell-research-and-clinical-translation. UR - https://www.isscr.org/news-publicationsss/isscr-news-articles/article-detail/2016/05/12/isscr-releases-updated-guidelines-for-stem-cell-research-and-clinical-translation ID - ref13 ER - TY - JOUR AU - Yuan, B. Z. PY - 2015 DA - 2015// TI - Establishing a quality control system for stem cell-based medicinal products in China JO - Tissue Eng Part A VL - 21 UR - https://doi.org/10.1089/ten.tea.2014.0498 DO - 10.1089/ten.tea.2014.0498 ID - Yuan2015 ER - TY - STD TI - Commission CP. Chinese Pharmacopoeia: China Medical Science Press; China, Beijing; 2015. ID - ref15 ER - TY - JOUR AU - Sensebé, L. AU - Bourin, P. AU - Tarte, K. PY - 2011 DA - 2011// TI - Good manufacturing practices production of mesenchymal stem/stromal cells JO - Hum Gene Ther VL - 22 UR - https://doi.org/10.1089/hum.2010.197 DO - 10.1089/hum.2010.197 ID - Sensebé2011 ER - TY - JOUR AU - Carol, M. S. AU - James, C. R. AU - Rebecca, K. H. AU - Nandini, S. AU - Rebecca, L. S. PY - 2011 DA - 2011// TI - Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products JO - Biologicals. VL - 39 UR - https://doi.org/10.1016/j.biologicals.2011.08.003 DO - 10.1016/j.biologicals.2011.08.003 ID - Carol2011 ER - TY - JOUR AU - Liu, Z. J. AU - Ying, Z. AU - Velazquez, O. C. PY - 2009 DA - 2009// TI - Trafficking and differentiation of mesenchymal stem cells JO - J Cell Biochem VL - 106 UR - https://doi.org/10.1002/jcb.22091 DO - 10.1002/jcb.22091 ID - Liu2009 ER - TY - JOUR AU - Liu, W. X. Y. AU - Gao, T. AU - Huang, F. AU - Wang, L. AU - Ding, L. AU - Wang, W. AU - Liu, S. AU - Dai, J. AU - Wang, B. PY - 2018 DA - 2018// TI - Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products JO - Stem Cell Res Ther VL - 9 UR - https://doi.org/10.1186/s13287-018-0920-3 DO - 10.1186/s13287-018-0920-3 ID - Liu2018 ER - TY - JOUR AU - Han, Y. F. AU - Tao, R. AU - Sun, T. J. AU - Chai, J. K. AU - Liu, J. PY - 2013 DA - 2013// TI - Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods JO - Cytotechnology. VL - 65 UR - https://doi.org/10.1007/s10616-012-9528-0 DO - 10.1007/s10616-012-9528-0 ID - Han2013 ER - TY - JOUR AU - Jacobs, M. R. AU - Good, C. E. AU - Fox, R. M. AU - Roman, K. P. AU - Lazarus, H. M. PY - 2013 DA - 2013// TI - Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine JO - Transfusion. VL - 53 UR - https://doi.org/10.1111/trf.12150 DO - 10.1111/trf.12150 ID - Jacobs2013 ER - TY - JOUR AU - Stormer, M. AU - Wood, E. M. AU - Schurig, U. AU - Karo, O. AU - Spreitzer, I. AU - McDonald, C. P. PY - 2014 DA - 2014// TI - Bacterial safety of cell-based therapeutic preparations, focusing on haematopoietic progenitor cells JO - Vox Sang VL - 106 UR - https://doi.org/10.1111/vox.12097 DO - 10.1111/vox.12097 ID - Stormer2014 ER - TY - JOUR AU - Cobo, F. AU - Stacey, G. N. AU - Hunt, C. AU - Cabrera, C. AU - Nieto, A. AU - Montes, R. PY - 2005 DA - 2005// TI - Microbiological control in stem cell banks: approaches to standardisation JO - Appl Microbiol Biotechnol VL - 68 UR - https://doi.org/10.1007/s00253-005-0062-2 DO - 10.1007/s00253-005-0062-2 ID - Cobo2005 ER - TY - JOUR AU - Dominici, M. AU - Blanc, K. AU - Mueller, I. AU - Slaper-Cortenbach, I. AU - Marini, F. AU - Krause, D. PY - 2006 DA - 2006// TI - Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement JO - Cytotherapy. VL - 8 UR - https://doi.org/10.1080/14653240600855905 DO - 10.1080/14653240600855905 ID - Dominici2006 ER - TY - JOUR AU - Torre, M. L. AU - Lucarelli, E. AU - Guidi, S. AU - Ferrari, M. AU - Alessandri, G. AU - Girolamo, L. PY - 2015 DA - 2015// TI - Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application JO - Stem Cells Dev. VL - 24 UR - https://doi.org/10.1089/scd.2014.0299 DO - 10.1089/scd.2014.0299 ID - Torre2015 ER - TY - JOUR AU - Yun, C. AU - Haixiang, S. AU - Hui, Z. AU - Xianghong, Z. AU - Xiaoqiu, T. AU - Guijun, Y. PY - 2018 DA - 2018// TI - Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial JO - Stem Cell Res Ther VL - 9 UR - https://doi.org/10.1186/s13287-018-0904-3 DO - 10.1186/s13287-018-0904-3 ID - Yun2018 ER - TY - JOUR AU - Daley, G. Q. AU - Hyun, I. AU - Apperley, J. F. AU - Barker, R. A. AU - Benvenisty, N. AU - Bredenoord, A. L. PY - 2016 DA - 2016// TI - Setting global standards for stem cell research and clinical translation: the 2016 ISSCR Guidelines JO - Stem Cell Rep VL - 6 UR - https://doi.org/10.1016/j.stemcr.2016.05.001 DO - 10.1016/j.stemcr.2016.05.001 ID - Daley2016 ER - TY - STD TI - Niazi SK. Specifications: test procedures and acceptance criteria for biotechnological/biological products. Handbook of pharmaceutical manufacturing formulations (semisolid products). 2009. doi: https://doi.org/10.3109/9781420081312.011. ID - ref28 ER - TY - JOUR AU - Aleksandra, K. AU - Urszula, K. PY - 2016 DA - 2016// TI - Mesenchymal stromal cells and tissue-specific progenitor cells: their role in tissue homeostasis JO - Stem Cells Int VL - 2016 ID - Aleksandra2016 ER - TY - JOUR AU - Sharma, R. R. AU - Pollock, K. AU - Hubel, A. AU - Mckenna, D. PY - 2014 DA - 2014// TI - Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices JO - Transfusion. VL - 54 UR - https://doi.org/10.1111/trf.12421 DO - 10.1111/trf.12421 ID - Sharma2014 ER - TY - JOUR AU - Zhao, S. AU - Wehner, R. AU - Bornhauser, M. AU - Wassmuth, R. AU - Bachmann, M. AU - Schmitz, M. PY - 2010 DA - 2010// TI - Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders JO - Stem Cells Dev VL - 19 UR - https://doi.org/10.1089/scd.2009.0345 DO - 10.1089/scd.2009.0345 ID - Zhao2010 ER - TY - STD TI - Tolar J, Blanc KL, Keating A, Blazar BR. Concise review: hitting the right spot with mesenchymal stromal cells. 2010;28:1446–55. ID - ref32 ER - TY - BOOK PY - 2008 DA - 2008// TI - Guideline on human cell-based medicinal products ID - ref33 ER - TY - JOUR AU - Aggarwal, S. PY - 2005 DA - 2005// TI - Human mesenchymal stem cells modulate allogeneic immune cell responses JO - Blood. VL - 105 UR - https://doi.org/10.1182/blood-2004-04-1559 DO - 10.1182/blood-2004-04-1559 ID - Aggarwal2005 ER - TY - JOUR AU - Mareschi, K. AU - Castiglia, S. AU - Sanavio, F. AU - Rustichelli, D. AU - Fagioli, F. PY - 2015 DA - 2015// TI - Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow JO - Amniotic Fluid Placenta Exp Hematol VL - 44 UR - https://doi.org/10.1016/j.exphem.2015.10.009 DO - 10.1016/j.exphem.2015.10.009 ID - Mareschi2015 ER - TY - JOUR AU - Salem, B. M. S. AU - Hensel, N. F. AU - Battiwalla, M. AU - Keyvanfar, K. AU - Stroncek, D. F. AU - Gee, A. P. AU - Hanley, P. J. AU - Bollard, C. M. AU - Ito, S. AU - Barrett, A. J. PY - 2015 DA - 2015// TI - Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency JO - Cytotherapy. VL - 17 UR - https://doi.org/10.1016/j.jcyt.2015.08.008 DO - 10.1016/j.jcyt.2015.08.008 ID - Salem2015 ER - TY - JOUR AU - Trento, C. AU - Dazzi, F. PY - 2010 DA - 2010// TI - Mesenchymal stem cells and innate tolerance: biology and clinical applications JO - Schweizerische Med Wochenschrift VL - 140 ID - Trento2010 ER - TY - JOUR AU - Najar, M. AU - Raicevic, G. AU - Fayyad-Kazan, H. AU - Bron, D. AU - Toungouz, M. AU - Lagneaux, L. PY - 2016 DA - 2016// TI - Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells JO - Cytotherapy. VL - 18 UR - https://doi.org/10.1016/j.jcyt.2015.10.011 DO - 10.1016/j.jcyt.2015.10.011 ID - Najar2016 ER -